ÂÜÀòÂÒÂ×

Feroze (Fez) Ujjainwalla brings 26 years of experience in small-molecule drug discovery to Terray. Prior to joining the company, Fez was Director of Business Development and Licensing (BD&L) at Merck & Co., Inc. He joined Merck in 1995 as Senior Research Chemist and rose to the rank of Executive Director of Chemistry before joining BD&L. He has led discovery programs from inception to early clinical development, delivering eight preclinical development candidates of which three proceeded to clinical trials – including the discovery of the first-in-class small molecule MC4R agonist, MK-0493, for the treatment of obesity. He has also led the search, scientific evaluation, and execution of licensing deals and strategic partnerships, establishing numerous deals across a range of deal types including dominant platform licenses for DNA-Encoded Library Technology and mRNA Display Technology. Fez earned his BSc in Chemistry and Ph.D. in Organic Chemistry from the Imperial College of Science, Technology & Medicine and completed his postdoctoral training at The University of Texas at Austin. He is an author of over 85 publications and patents.